Founders
David Neale - CEO
Over 25 years experience in managing and shaping businesses in the medical field, covering general commodities, services and medical devices in the fields of cardiology, renal therapies, neuromodulation and orthopedics. Head of AF Solutions for Medtronic in Europe/ Asia, with responsibility to integrate Cryocath Laboratories and Ablation Frontiers acquisitions into the Medtronic AF portfolio.
Proven experience in establishing new businesses. Entrepreneurial and strategic attitude towards identifying and exploiting opportunities and strong leadership in implementing value driven plans. Good track record in the development and launch of new products, exploring new businesses, business models and setting up multiple channels of distribution. Experienced in negotiating with high ranked government officials, c-suite and negotiating mergers and acquisitions.
Strong and effective leader in coordinating projects across all functions, including engineering, R&D, clinical, regulatory and finance.
Start up, small/medium (PME) enterprise coach and mentor.
B.S. degree in Pharmacy-Biochemistry and Masters in Industrial Administration and MBA from the University of Sao Paulo Brazil
https://www.linkedin.com/in/david-neale/
Randy Werneth - CTO
Over 25 years of experience in both small entrepreneurial and Fortune 500 corporations in the medical device industry.
Mr. Werneth has successfully started and raised venture capital for several start-up companies including Maxwell Biomedical, Acutus Medical, Securus Medical Group (acquired by Boston Scientific), Ablation Frontiers (acquired by Medtronic), and CryoTherapeuticsand a team member of CryterionMedical, (acquired by Boston Scientific).
Randy has taken each start-up from concept, through multi-series of financing and from an idea to commercial approvals and early revenue.
Mr. Werneth previously held senior level positions at Medtronic, Micro Therapeutics and Edwards Lifesciences where he led Research & Development Departments to engineer from concepts through commercial launch. He also sits on the board of several venture funded medical device companies in the US and Europe.